Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement
MH Baumann, C Strange, JE Heffner, R Light, TJ Kirby… - Chest, 2001 - Elsevier
Objective Provide explicit expert-basedconsensus recommendations for the management of
adults with primary andsecondary spontaneous pneumothoraces in an emergency …
adults with primary andsecondary spontaneous pneumothoraces in an emergency …
Neurocognitive impairment in obstructive sleep apnea
C Lal, C Strange, D Bachman - Chest, 2012 - Elsevier
… Silent brain infarction is associated with increased markers of platelet activation (soluble
CD40L and soluble P-selectin) and systemic inflammation (C-reactive protein), which likely …
CD40L and soluble P-selectin) and systemic inflammation (C-reactive protein), which likely …
[HTML][HTML] Lithium-ion battery data and where to find it
… These experiments were performed on 28 Li-ion 18650 3.5 Ah commercial cells for a
range of temperatures (0 C, 10 C, 25 C and 45 C), discharge C-rates (0.5C, 3C) and charge …
range of temperatures (0 C, 10 C, 25 C and 45 C), discharge C-rates (0.5C, 3C) and charge …
[HTML][HTML] Cyclophosphamide versus placebo in scleroderma lung disease
…, DE Furst, E Arriola, R Silver, C Strange… - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a double-blind, randomized, placebo-controlled trial to determine
the effects of oral cyclophosphamide on lung function and health-related symptoms in …
the effects of oral cyclophosphamide on lung function and health-related symptoms in …
Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter …
…, D Gloskey, D Longworth, L Liucchi, C Strange… - Jama, 1995 - jamanetwork.com
Objective. —To evaluate the efficacy and safety of anti—tumor necrosis factor α monoclonal
antibody (TNF-α MAb) in the treatment of patients with sepsis syndrome. Design. —…
antibody (TNF-α MAb) in the treatment of patients with sepsis syndrome. Design. —…
[BOOK][B] Educating by Design: Creating Campus Learning Environments That Work. The Jossey-Bass Higher and Adult Education Series.
CC Strange, JH Banning - 2001 - ERIC
This book offers a select sampling of concepts and models organized around a distinctive
framework and reflective of themes critical to the successful functioning of higher education …
framework and reflective of themes critical to the successful functioning of higher education …
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease
…, P Rottoli, C Saltini, M Selman, C Strange… - American journal of …, 2012 - atsjournals.org
Background: The clinical utility of bronchoalveolar lavage fluid (BAL) cell analysis for the
diagnosis and management of patients with interstitial lung disease (ILD) has been a subject of …
diagnosis and management of patients with interstitial lung disease (ILD) has been a subject of …
[HTML][HTML] Efficacy and safety of sirolimus in lymphangioleiomyomatosis
…, Y Inoue, J Moss, LG Singer, C Strange… - … England Journal of …, 2011 - Mass Medical Soc
Background Lymphangioleiomyomatosis (LAM) is a progressive, cystic lung disease in
women; it is associated with inappropriate activation of mammalian target of rapamycin (mTOR) …
women; it is associated with inappropriate activation of mammalian target of rapamycin (mTOR) …
[HTML][HTML] A randomized study of endobronchial valves for advanced emphysema
FC Sciurba, A Ernst, FJF Herth, C Strange… - … England Journal of …, 2010 - Mass Medical Soc
Background Endobronchial valves that allow air to escape from a pulmonary lobe but not
enter it can induce a reduction in lobar volume that may thereby improve lung function and …
enter it can induce a reduction in lobar volume that may thereby improve lung function and …
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group …
…, S Kafaja, R Silver, V Steen, C Strange… - The lancet Respiratory …, 2016 - thelancet.com
Background 12 months of oral cyclophosphamide has been shown to alter the progression
of scleroderma-related interstitial lung disease when compared with placebo. However, …
of scleroderma-related interstitial lung disease when compared with placebo. However, …